Preparing Your Drug for Clinical Success: Strategies and Considerations
July 8, 2020
The pharmaceutical industry continues to experience decreasing productivity and high levels of attrition. Inflation of molecule physicochemical properties and complexities in clinical trial protocols stand among the main reasons for these trends. The most successful companies can leverage different expertise, manage risks, and follow logical sequences of operations in an integrated manner to speed development.
Hosted by the Catalent Applied Drug Delivery Institute, with the Department of Pharmaceutical Sciences (DISFARM), University of Milan, and Leads to Development, this webinar will focus on the key considerations for transitioning a molecule from discovery through clinical studies including molecule developability assessment, phase-appropriate formulation selection, integration of product development and clinical supply as well as regulatory requirements for advancing a developmental candidate to clinical trials.
The Catalent Applied Drug Delivery Institute brings together pharmaceutical innovators, organizations, and academia to improve clinical outcomes, medication delivery profiles, patient adherence and treatment efficacy.